Your Cart is Empty
A growing wave of litigation is hitting the makers of blockbuster weight-loss and diabetes drugs. More than 4,000 lawsuits are targeting the makers of GLP-1 medications. Numerous lawsuits claim severe health problems, ranging from sudden loss of sight and significant vision impairment to neurological disorders and reduced motor control and debilitating gastrointestinal harm.
These drugs have surged in popularity because they suppress appetite and promote weight loss. They work like a natural hormone that slows digestion, triggers insulin release, and helps people feel full longer, while also showing promise for kidney disease and addiction treatment.
It is estimated that over 30 million people have turned to GLP-1 medications for diabetes treatment or weight reduction. Common side effects including nausea, vomiting, and diarrhea are well documented, but clinical studies, safety reports, and continued research have also identified potentially serious complications linked to these medications.
The lawsuits accuse manufacturers of not fully informing doctors and patients about serious risks linked to the drugs. Plaintiffs describe severe complications that led to intensive treatment, urgent surgeries, and in certain cases, lifelong injuries.
Although the FDA has expanded warnings on some drugs to highlight risks, many believe the full scope of health conditions linked to these drugs has yet to be adequately communicated, meaning patients may still be harmed.
Drugmakers continue to stand by the safety of these medications, saying they will challenge the lawsuits.
The gut microbiome is the community of trillions of bacteria, fungi and viruses that primarily live in the colon. These tiny organisms help digest food while producing compounds that can influence many aspects of both physical and mental health. Researchers have uncovered a link between specific gut bacteria and biological aging, adding to growing evidence that the gut microbiome may affect how we age.
Many of us spend hours sitting each day without giving it much thought. But research suggests that long, uninterrupted periods of sitting may do more than slow your metabolism. They could also increase your risk of dying from cancer. Now, a new study suggests it's not just how much you sit that matters, but how often you get up and move.
Could the speed of your daily walk reveal how well your brain is aging? According to new research, the answer may be yes. Scientists found that senior adults who naturally walked at a brisker pace showed bettermemory, thinking skills, and healthier brain characteristics than slower walkers, suggesting that something as simple as walking faster could help support long-term brain health.